Definium Therapeutics (DFTX) Free Cash Flow (QoQ) (2020 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | Definium Therapeutics | 2.42 Bn | 2.06 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.80% |
| Dec 31, 2025 | -45.35% |
| Sep 30, 2025 | 0.11% |
| Jun 30, 2025 | -0.61% |
| Mar 31, 2025 | -16.05% |
| Dec 31, 2024 | -47.47% |
| Sep 30, 2024 | 14.00% |
| Jun 30, 2024 | -20.43% |
| Mar 31, 2024 | 19.28% |
| Dec 31, 2023 | -23.68% |
| Sep 30, 2023 | -20.09% |
| Jun 30, 2023 | -3.86% |
| Mar 31, 2023 | -3.75% |
| Dec 31, 2022 | -38.21% |
| Sep 30, 2022 | 38.54% |
| Jun 30, 2022 | -17.57% |
| Mar 31, 2022 | -64.25% |
| Dec 31, 2021 | 53.32% |
| Sep 30, 2021 | -50.23% |
| Jun 30, 2021 | -11.29% |
| Mar 31, 2021 | -40.55% |
| Dec 31, 2020 | -23.05% |
| Sep 30, 2020 | -4.56% |
| Jun 30, 2020 | -8.84% |
| Mar 31, 2020 | -59.42% |